Bipartisan House bill introduced to prevent 340B cuts

AHA News Now

Reps. David McKinley (R-WV) and Mike Thompson (D-CA) last night introduced H.R. 4392, a bill that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B Drug Pricing Program. The Centers for Medicare & Medicaid Services recently released a final... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare

Hospital groups file lawsuit to stop OPPS payment cut for 340B hospitals

AHA News Now

The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today filed a federal lawsuit to prevent the Centers for Medicare & Medicaid Services from reducing Medicare payments for hospital outpatient drugs under the 340B Drug Pricing Program by nearly 30%. Eastern... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, regulation

CMS releases 2018 OPPS/ASC final rule

AHA News Now

The Centers for Medicare & Medicaid Services today announced it will update the hospital outpatient prospective payment system rates by 1.35% in calendar year 2018 compared to CY 2017. The rule also finalizes CMS’s proposal to drastically cut Medicare payment for drugs that are acquired under the 340B... read more

Topic: Advocacy and Public Policy
Tag: 340B

340B providers in disaster areas can register early for program

AHA News Now

The Health Resources and Services Administration has announced that 340B Drug Pricing Program hospitals in areas affected by recent natural disasters can immediately enroll in the program instead of waiting for the normal registration period. “HRSA recognizes that circumstances surrounding disaster relief... read more

Topic: Access and Coverage
Tag: 340B

Hearing highlights benefits of 340B Drug Pricing Program

AHA News Now

The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care organizations at... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicare, Medicaid, drug prices

AHA Stat Blog: Report misses mark on 340B program

AHA News Now

The latest report from a group financed and backed by the pharmaceutical industry “continues to misrepresent” the 340B Drug Pricing Program and its “successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, drug prices

57 senators urge CMS to consider feedback before finalizing 340B proposal

AHA News Now

Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to “carefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B program is... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation

AHA, AAMC express support for 340B program

AHA News Now

The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce Committee... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

Majority of House members urge CMS to abandon proposal to cut 340B program

AHA News Now

Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “Given the important role that the 340B program plays in our... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

HRSA delays to July effective date of 340B drug ceiling price rule

AHA News Now

The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. “We are delaying the effective date of the Jan. 5, 2017, final rule to July 1, 2018, because the delay will... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

Keyword Search

Types

Date